Inventor
Bruno Giethlen
Inventor
Altorf, FR
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
PatentTitleYear
10,889,563Deoxyuridine triphosphatase inhibitors202110,457,673Heteroatom containing deoxyuridine triphosphatase inhibitors201910,227,326Deoxyuridine triphosphatase inhibitors20199,994,518Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof20189,809,571'Deoxyuridine triphosphatase inhibitors'20179,790,173'Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof-I'20179,790,214'Heteroatom containing deoxyuridine triphosphatase inhibitors'20179,434,745'7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease'20169,062,013'Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof'20158,993,573'2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors'20158,962,627'Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors'20158,835,435'2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors'20148,450,302'2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors'20138,404,683'Inhibitors of the interaction between MDM2 and P53'20138,377,961'Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53'20138,110,591'2-aminoaryloxazole compounds as tyrosine kinase inhibitors'20128,088,795'Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53'20128,071,590'9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials'20118,044,090'N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor'20117,834,016'Inhibitors of the interaction between MDM2 and p53'20107,718,676'2-aminoaryloxazole compounds as tyrosine kinase inhibitors'20107,713,965'7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials'20107,157,488'N-(2-Arylethyl) benzylamines as antagonists of the 5-HT6 receptor'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2021Based in Altorf, FR· patent location history
2010–2015Patents assigned to AB SCIENCE (5)· patent assignee history
2010–2013Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2010–2018Based in Illkirch, FR· patent location history
2011–2015Patents assigned to GIETHLEN BRUNO (9)· patent assignee history
2012–2014Patents assigned to CIUFOLINI MARCO (3)· patent assignee history
2015Based in Altofr, FR· patent location history
2017–2021Patents assigned to UNIV SOUTHERN CALIFORNIA (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GIETHLEN BRUNOself | 9 | 2011–2015 |
| AB SCIENCE | 5 | 2010–2015 |
| UNIV SOUTHERN CALIFORNIA | 5 | 2017–2021 |
| JANSSEN PHARMACEUTICA NV | 4 | 2010–2013 |
| CIUFOLINI MARCO | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Altorf, FR | 17 | 2007–2021 |
| Illkirch, FR | 5 | 2010–2018 |
| Altofr, FR | 1 | 2015 |